Evidence mapPaperPMID 40307351Full record

ArticleLab animal2025

Intranasal delivery of drugs to the central nervous system of adult zebrafish.

David S Galstyan, Tatyana O Kolesnikova, Konstantin A Demin, Yaroslav A Dubrovskii, Ekaterina Murashko, Elizaveta Kessenikh, Nikita P Ilyin, Aleksey N Ikrin, Anastasia M Moskalenko, Murilo S de Abreu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Lab animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David S GalstyanWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.
Tatyana O KolesnikovaNeuroscience Department, Sirius University of Science and Technology, Sirius Federal Territory, Russia.
Konstantin A DeminInstitute of Experimental Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.
Yaroslav A DubrovskiiWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.
Ekaterina MurashkoWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.ORCID 0000-0002-8723-8622
Elizaveta KessenikhWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.ORCID 0000-0001-8700-9590
Nikita P IlyinWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.
Aleksey N IkrinNeuroscience Department, Sirius University of Science and Technology, Sirius Federal Territory, Russia.
Anastasia M MoskalenkoNeuroscience Department, Sirius University of Science and Technology, Sirius Federal Territory, Russia.ORCID 0000-0003-1576-8410
Murilo S de AbreuGraduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil. abreu_murilo@hotmail.com.ORCID 0000-0001-5562-0715
Longen YangDepartment of Biological Sciences, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Allan V KalueffWorld Class Research Center for Personalized Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia. avkalueff@gmail.com.ORCID 0000-0002-7525-1950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small teleost zebrafish (Danio rerio) has become a critically important laboratory animal in biomedicine. One of their key practical advantages, the convenient method of small-molecule administration via water immersion, has certain problems with dosing precision and drug delivery. Here, we present a simple protocol for the intranasal delivery of neuroactive drugs in adult zebrafish using arecoline and nicotine, two well-studied reference neuroactive drugs chosen for the proof of concept. Adult fish received 1 μL water solution of arecoline (1 and 10 mg/mL) or nicotine tartrate (5 and 10 mg/mL) or the same volume of drug-free water (control) into both nostrils, followed by behavioral testing in the novel tank test 5 min later. Mass spectrometry analyses confirmed that both drugs rapidly reached the zebrafish brain following intranasal administration. Intranasally administered arecoline (10 mg/mL) and nicotine (5 and 10 mg/mL) demonstrated overt behavioral profiles, evoking characteristic anxiolytic-like effects in zebrafish similar to those observed here for a standard 20-min water immersion method (10 mg/L arecoline or 30 mg/L nicotine). Overall, we showed that neuroactive drugs can be delivered to adult zebrafish intranasally to exert central effects, which may (at least for some drugs) occur faster and can need smaller drug quantities than for the water immersion delivery.

Indexed as

Administration, IntranasalArecolineNicotineZebrafishAnimalsBehavior, AnimalBrainMaleArecolineNicotine

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.